ActoBiotics

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Compositions and methods for the treatment of type 1 diabetes
US 10905727 B2申请人: INTREXON ACTOBIOTICS N V优先权: 2016
CN
US
4 件公开
Genetically modified bacteria stably expressing IL-10 and insulin
US 10858663 B2申请人: INTREXON ACTOBIOTICS N V优先权: 2016
CN
US
4 件公开
Modified gram positive bacteria and uses thereof
- US 9347036 B2
  申请人: INTREXON ACTOBIOTICS NV优先权: 2011
  US
  4 件公开
- US 9458467 B2
  申请人: INTREXON ACTOBIOTICS NV优先权: 2011
  US
  2 件公开
Cryoprotectants for freeze drying of lactic acid bacteria
US 9574169 B2申请人: CORVELEYN SAM优先权: 2009
US
3 件公开
Induction of mucosal tolerance to antigens
US 9526750 B2申请人: INTREXON ACTOBIOTICS NV优先权: 2014
US
3 件公开
Mucoadhesive microorganism
US 10808014 B2申请人: INTREXON ACTOBIOTICS N V优先权: 2017
US
3 件公开
Polycistronic expression system for bacteria
US 9920324 B2申请人: VANDEN BROUCKE KLAAS优先权: 2011
US
2 件公开
Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus
US 10143729 B2申请人: INTREXON ACTOBIOTICS NV优先权: 2013
US
2 件公开
ANTI-TNF ALPHA PRODUCING LACTIC ACID BACTERIA FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
EP 3181141 A1申请人: INTREXON ACTOBIOTICS NV优先权: 2005
EP
REDUCED COLONIZATION OF MICROBES AT THE MUCOSA
EP 3933029 A3申请人: INTREXON ACTOBIOTICS NV优先权: 2008
EP